Please Wait.....
Report
Immunohistochemistry Market By Product (Antibody, Reagents, Kits, Equipment), By Application (Diagnosis, Research Applications, Forensic), By End User (Hospital and Diagnostic Labs, Research Institutes and Academic Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Market Report I 2022-07-01 I 385 Pages I Allied Market Research
The global immunohistochemistry market was valued at $2,388.5 million in 2021 and is projected to reach $4,530.56 million by 2031, registering a CAGR of 6.5% from 2022 to 2031. Immunohistochemistry is a valuable technique that is used for the identification and visualization of tissue antigens in biological research and clinical diagnostics. In addition, Immunohistochemistry (IHC) is a diagnostic technique that is conducted in a laboratory. It involves performing special tests on your biopsy tissue sample to help diagnose the disease more precisely.
The key factors that drive the growth of the market are an increase in the prevalence of the geriatric population, a rise in the prevalence of chronic disease and a rise in healthcare expenditure boosts the market growth. However, a dearth of skilled professionals restricts the market growth in the forecast period. Moreover, rise in technological advancements in IHC, increase in a number of product approvals and availability of reimbursements for IHC tests offer lucrative opportunities to the market player operating in the immunohistochemistry market.
The global Immunohistochemistry market is segmented into product, application, end-user, and region. By product, the market is categorized into antibodies, reagents, equipment, and kits. the antibody segment is further classified into primary antibodies and secondary antibodies. By reagent segment is further classified into histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, organic solvents, proteolytic enzymes, diluents, and other reagents equipment segment is further classified into slide-staining systems, tissue processing systems, slide scanners and other. kits segment is further classified into IHC kits for human tissue, IHC kits for animal tissue. By application, the market is segmented into diagnosis, research applications, and forensics. By diagnosis, the segment is further bifurcated into cancer, infectious diseases, autoimmune diseases, nephrological diseases, neurological diseases, and other diseases. By research, the application segment is further classified into drug testing and others. By end user, the market is categorized into hospitals & diagnostic laboratories, academic & research institutes, and other end users.
By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global Immunohistochemistry market are Abcam PLC, Agilent Technologies Inc, Becton, Dickinson & Company, Biocare Medical LLC, Biogenex Laboratories, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc, Diagnostic Biosystems Inc., Eagle Biosciences Inc, F. Hoffman-La Roche AG, Genemed Biotechnologies Inc, Merck KGaA, Miltenyi Biotec GmbH, PerkinElmer Inc, Rockland Immunochemicals Inc, Takara Bio. Inc and thermo Fischer Scientific, Inc
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the immunohistochemistry market analysis from 2021 to 2031 to identify the prevailing immunohistochemistry market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the immunohistochemistry market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global immunohistochemistry market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Antibody
- Type
- Primary Antibodies
- Secondary Antibodies
- Reagents
- Type
- Histological Stains
- Blocking Sera and Reagents
- Chromogenic Substrates
- Diluents
- Fixation Reagents
- Organic Solvents
- Proteolytic Enzymes
- Other
- Kits
- Type
- IHC Kits for Animal Tissue
- IHC Kits for Human Tissue
- Equipment
- Type
- Slide staining Systems
- Tissue Processing Systems
- Slide Scanners
- Others
By Application
- Diagnosis
- Type
- Infectious diseases
- Neurological diseases
- Nephrological diseases
- Autoimmune diseases
- Cancer
- Others
- Research Applications
- Type
- Drug Testing
- Others
- Forensic
By End User
- Hospital and Diagnostic Labs
- Research Institutes and Academic Institutes
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Italy
- Spain
- Rest of Europe
- Germany
- France
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Agilent Technologies Inc
- Abcam Plc
- F hoffman La Roche
- Merck Kgaa
- Biorad Laboratories
- Thermofischer Scientific Inc
- Cell Signaling Technology, Inc
- Bio SB
- Takara Bio, Inc
- PHC Holdings Corporation
- Miltenyi Biotec
- CANDOR Bioscience GmbH
- Sakura Finetek Japan Co., Ltd
- Eagle Biosciences, Inc.
- Biocare Medical, LLC
- Elabscience, Inc.
- Biogenex Laboratories
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Antibody
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Antibody Immunohistochemistry Market by Type
4.3 Reagents
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.3.4 Reagents Immunohistochemistry Market by Type
4.4 Kits
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.4.4 Kits Immunohistochemistry Market by Type
4.5 Equipment
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.5.4 Equipment Immunohistochemistry Market by Type
CHAPTER 5: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Diagnosis
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Diagnosis Immunohistochemistry Market by Type
5.3 Research Applications
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.3.4 Research Applications Immunohistochemistry Market by Type
5.4 Forensic
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: IMMUNOHISTOCHEMISTRY MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospital and Diagnostic Labs
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Research Institutes and Academic Institutes
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: IMMUNOHISTOCHEMISTRY MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest Of Asia Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Application
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Agilent Technologies Inc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Abcam Plc
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 F hoffman La Roche
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Merck Kgaa
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Biorad Laboratories
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Thermofischer Scientific Inc
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Cell Signaling Technology, Inc
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Bio SB
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Takara Bio, Inc
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 PHC Holdings Corporation
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 Miltenyi Biotec
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 CANDOR Bioscience GmbH
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
9.13 Sakura Finetek Japan Co., Ltd
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Operating business segments
9.13.4 Product portfolio
9.13.5 Business performance
9.13.6 Key strategic moves and developments
9.14 Eagle Biosciences, Inc.
9.14.1 Company overview
9.14.2 Company snapshot
9.14.3 Operating business segments
9.14.4 Product portfolio
9.14.5 Business performance
9.14.6 Key strategic moves and developments
9.15 Biocare Medical, LLC
9.15.1 Company overview
9.15.2 Company snapshot
9.15.3 Operating business segments
9.15.4 Product portfolio
9.15.5 Business performance
9.15.6 Key strategic moves and developments
9.16 Elabscience, Inc.
9.16.1 Company overview
9.16.2 Company snapshot
9.16.3 Operating business segments
9.16.4 Product portfolio
9.16.5 Business performance
9.16.6 Key strategic moves and developments
9.17 Biogenex Laboratories
9.17.1 Company overview
9.17.2 Company snapshot
9.17.3 Operating business segments
9.17.4 Product portfolio
9.17.5 Business performance
9.17.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR ANTIBODY, BY REGION, 2021-2031 ($MILLION)
TABLE 3. IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODY, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. GLOBAL ANTIBODY IMMUNOHISTOCHEMISTRY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 5. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR REAGENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 6. IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 7. GLOBAL REAGENTS IMMUNOHISTOCHEMISTRY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 8. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR KITS, BY REGION, 2021-2031 ($MILLION)
TABLE 9. IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. GLOBAL KITS IMMUNOHISTOCHEMISTRY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 11. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR EQUIPMENT, BY REGION, 2021-2031 ($MILLION)
TABLE 12. IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. GLOBAL EQUIPMENT IMMUNOHISTOCHEMISTRY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 14. GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 15. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR DIAGNOSIS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSIS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. GLOBAL DIAGNOSIS IMMUNOHISTOCHEMISTRY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 18. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR RESEARCH APPLICATIONS, BY REGION, 2021-2031 ($MILLION)
TABLE 19. IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. GLOBAL RESEARCH APPLICATIONS IMMUNOHISTOCHEMISTRY MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 21. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR FORENSIC, BY REGION, 2021-2031 ($MILLION)
TABLE 22. IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 24. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR HOSPITAL AND DIAGNOSTIC LABS, BY REGION, 2021-2031 ($MILLION)
TABLE 25. IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITAL AND DIAGNOSTIC LABS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 26. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR RESEARCH INSTITUTES AND ACADEMIC INSTITUTES, BY REGION, 2021-2031 ($MILLION)
TABLE 27. IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH INSTITUTES AND ACADEMIC INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. IMMUNOHISTOCHEMISTRY MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 29. IMMUNOHISTOCHEMISTRY MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 31. NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 32. NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 33. NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 34. NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 35. U.S. IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 36. U.S. IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 37. U.S. IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 38. CANADA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 39. CANADA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 40. CANADA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 41. MEXICO IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 42. MEXICO IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 43. MEXICO IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 44. EUROPE IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 45. EUROPE IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 46. EUROPE IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 47. EUROPE IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 48. GERMANY IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 49. GERMANY IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 50. GERMANY IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 51. FRANCE IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 52. FRANCE IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 53. FRANCE IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 54. UK IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 55. UK IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 56. UK IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 57. ITALY IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 58. ITALY IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 59. ITALY IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 60. SPAIN IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 61. SPAIN IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 62. SPAIN IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 63. REST OF EUROPE IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 64. REST OF EUROPE IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 65. REST OF EUROPE IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 68. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 69. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 70. JAPAN IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 71. JAPAN IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 72. JAPAN IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 73. CHINA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 74. CHINA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 75. CHINA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 76. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 77. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 78. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 79. INDIA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 80. INDIA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 81. INDIA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 82. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 83. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 84. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 85. REST OF ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 86. REST OF ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 87. REST OF ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 88. LAMEA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 89. LAMEA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 90. LAMEA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 91. LAMEA IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 92. BRAZIL IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 93. BRAZIL IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 94. BRAZIL IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 95. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 96. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 97. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 98. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 99. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 100. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 101. REST OF LAMEA IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 102. REST OF LAMEA IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 103. REST OF LAMEA IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 104.AGILENT TECHNOLOGIES INC: COMPANY SNAPSHOT
TABLE 105.AGILENT TECHNOLOGIES INC: OPERATING SEGMENTS
TABLE 106.AGILENT TECHNOLOGIES INC: PRODUCT PORTFOLIO
TABLE 107.AGILENT TECHNOLOGIES INC: NET SALES,
TABLE 108.AGILENT TECHNOLOGIES INC: KEY STRATERGIES
TABLE 109.ABCAM PLC: COMPANY SNAPSHOT
TABLE 110.ABCAM PLC: OPERATING SEGMENTS
TABLE 111.ABCAM PLC: PRODUCT PORTFOLIO
TABLE 112.ABCAM PLC: NET SALES,
TABLE 113.ABCAM PLC: KEY STRATERGIES
TABLE 114.F HOFFMAN LA ROCHE: COMPANY SNAPSHOT
TABLE 115.F HOFFMAN LA ROCHE: OPERATING SEGMENTS
TABLE 116.F HOFFMAN LA ROCHE: PRODUCT PORTFOLIO
TABLE 117.F HOFFMAN LA ROCHE: NET SALES,
TABLE 118.F HOFFMAN LA ROCHE: KEY STRATERGIES
TABLE 119.MERCK KGAA: COMPANY SNAPSHOT
TABLE 120.MERCK KGAA: OPERATING SEGMENTS
TABLE 121.MERCK KGAA: PRODUCT PORTFOLIO
TABLE 122.MERCK KGAA: NET SALES,
TABLE 123.MERCK KGAA: KEY STRATERGIES
TABLE 124.BIORAD LABORATORIES: COMPANY SNAPSHOT
TABLE 125.BIORAD LABORATORIES: OPERATING SEGMENTS
TABLE 126.BIORAD LABORATORIES: PRODUCT PORTFOLIO
TABLE 127.BIORAD LABORATORIES: NET SALES,
TABLE 128.BIORAD LABORATORIES: KEY STRATERGIES
TABLE 129.THERMOFISCHER SCIENTIFIC INC: COMPANY SNAPSHOT
TABLE 130.THERMOFISCHER SCIENTIFIC INC: OPERATING SEGMENTS
TABLE 131.THERMOFISCHER SCIENTIFIC INC: PRODUCT PORTFOLIO
TABLE 132.THERMOFISCHER SCIENTIFIC INC: NET SALES,
TABLE 133.THERMOFISCHER SCIENTIFIC INC: KEY STRATERGIES
TABLE 134.CELL SIGNALING TECHNOLOGY, INC: COMPANY SNAPSHOT
TABLE 135.CELL SIGNALING TECHNOLOGY, INC: OPERATING SEGMENTS
TABLE 136.CELL SIGNALING TECHNOLOGY, INC: PRODUCT PORTFOLIO
TABLE 137.CELL SIGNALING TECHNOLOGY, INC: NET SALES,
TABLE 138.CELL SIGNALING TECHNOLOGY, INC: KEY STRATERGIES
TABLE 139.BIO SB: COMPANY SNAPSHOT
TABLE 140.BIO SB: OPERATING SEGMENTS
TABLE 141.BIO SB: PRODUCT PORTFOLIO
TABLE 142.BIO SB: NET SALES,
TABLE 143.BIO SB: KEY STRATERGIES
TABLE 144.TAKARA BIO, INC: COMPANY SNAPSHOT
TABLE 145.TAKARA BIO, INC: OPERATING SEGMENTS
TABLE 146.TAKARA BIO, INC: PRODUCT PORTFOLIO
TABLE 147.TAKARA BIO, INC: NET SALES,
TABLE 148.TAKARA BIO, INC: KEY STRATERGIES
TABLE 149.PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 150.PHC HOLDINGS CORPORATION: OPERATING SEGMENTS
TABLE 151.PHC HOLDINGS CORPORATION: PRODUCT PORTFOLIO
TABLE 152.PHC HOLDINGS CORPORATION: NET SALES,
TABLE 153.PHC HOLDINGS CORPORATION: KEY STRATERGIES
TABLE 154.MILTENYI BIOTEC: COMPANY SNAPSHOT
TABLE 155.MILTENYI BIOTEC: OPERATING SEGMENTS
TABLE 156.MILTENYI BIOTEC: PRODUCT PORTFOLIO
TABLE 157.MILTENYI BIOTEC: NET SALES,
TABLE 158.MILTENYI BIOTEC: KEY STRATERGIES
TABLE 159.CANDOR BIOSCIENCE GMBH: COMPANY SNAPSHOT
TABLE 160.CANDOR BIOSCIENCE GMBH: OPERATING SEGMENTS
TABLE 161.CANDOR BIOSCIENCE GMBH: PRODUCT PORTFOLIO
TABLE 162.CANDOR BIOSCIENCE GMBH: NET SALES,
TABLE 163.CANDOR BIOSCIENCE GMBH: KEY STRATERGIES
TABLE 164.SAKURA FINETEK JAPAN CO., LTD: COMPANY SNAPSHOT
TABLE 165.SAKURA FINETEK JAPAN CO., LTD: OPERATING SEGMENTS
TABLE 166.SAKURA FINETEK JAPAN CO., LTD: PRODUCT PORTFOLIO
TABLE 167.SAKURA FINETEK JAPAN CO., LTD: NET SALES,
TABLE 168.SAKURA FINETEK JAPAN CO., LTD: KEY STRATERGIES
TABLE 169.EAGLE BIOSCIENCES, INC.: COMPANY SNAPSHOT
TABLE 170.EAGLE BIOSCIENCES, INC.: OPERATING SEGMENTS
TABLE 171.EAGLE BIOSCIENCES, INC.: PRODUCT PORTFOLIO
TABLE 172.EAGLE BIOSCIENCES, INC.: NET SALES,
TABLE 173.EAGLE BIOSCIENCES, INC.: KEY STRATERGIES
TABLE 174.BIOCARE MEDICAL, LLC: COMPANY SNAPSHOT
TABLE 175.BIOCARE MEDICAL, LLC: OPERATING SEGMENTS
TABLE 176.BIOCARE MEDICAL, LLC: PRODUCT PORTFOLIO
TABLE 177.BIOCARE MEDICAL, LLC: NET SALES,
TABLE 178.BIOCARE MEDICAL, LLC: KEY STRATERGIES
TABLE 179.ELABSCIENCE, INC.: COMPANY SNAPSHOT
TABLE 180.ELABSCIENCE, INC.: OPERATING SEGMENTS
TABLE 181.ELABSCIENCE, INC.: PRODUCT PORTFOLIO
TABLE 182.ELABSCIENCE, INC.: NET SALES,
TABLE 183.ELABSCIENCE, INC.: KEY STRATERGIES
TABLE 184.BIOGENEX LABORATORIES: COMPANY SNAPSHOT
TABLE 185.BIOGENEX LABORATORIES: OPERATING SEGMENTS
TABLE 186.BIOGENEX LABORATORIES: PRODUCT PORTFOLIO
TABLE 187.BIOGENEX LABORATORIES: NET SALES,
TABLE 188.BIOGENEX LABORATORIES: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.IMMUNOHISTOCHEMISTRY MARKET SEGMENTATION
FIGURE 2.IMMUNOHISTOCHEMISTRY MARKET,2021-2031
FIGURE 3.IMMUNOHISTOCHEMISTRY MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.IMMUNOHISTOCHEMISTRY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.IMMUNOHISTOCHEMISTRY MARKET,BY PRODUCT,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ANTIBODY IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF REAGENTS IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF KITS IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF EQUIPMENT IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
FIGURE 17.IMMUNOHISTOCHEMISTRY MARKET,BY APPLICATION,2021(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DIAGNOSIS IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF RESEARCH APPLICATIONS IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF FORENSIC IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
FIGURE 21.IMMUNOHISTOCHEMISTRY MARKET,BY END USER,2021(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HOSPITAL AND DIAGNOSTIC LABS IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF RESEARCH INSTITUTES AND ACADEMIC INSTITUTES IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS IMMUNOHISTOCHEMISTRY MARKET,2021-2031(%)
FIGURE 25.IMMUNOHISTOCHEMISTRY MARKET BY REGION,2021
FIGURE 26.U.S. IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 27.CANADA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 28.MEXICO IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 29.GERMANY IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 30.FRANCE IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 31.UK IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 32.ITALY IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 33.SPAIN IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 34.REST OF EUROPE IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 35.JAPAN IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 36.CHINA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 37.AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 38.INDIA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 39.SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 40.REST OF ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 41.BRAZIL IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 42.SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 43.SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 44.REST OF LAMEA IMMUNOHISTOCHEMISTRY MARKET,2021-2031($MILLION)
FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 49.COMPETITIVE DASHBOARD
FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 51.AGILENT TECHNOLOGIES INC.: NET SALES ,($MILLION)
FIGURE 52.ABCAM PLC.: NET SALES ,($MILLION)
FIGURE 53.F HOFFMAN LA ROCHE.: NET SALES ,($MILLION)
FIGURE 54.MERCK KGAA.: NET SALES ,($MILLION)
FIGURE 55.BIORAD LABORATORIES.: NET SALES ,($MILLION)
FIGURE 56.THERMOFISCHER SCIENTIFIC INC.: NET SALES ,($MILLION)
FIGURE 57.CELL SIGNALING TECHNOLOGY, INC.: NET SALES ,($MILLION)
FIGURE 58.BIO SB.: NET SALES ,($MILLION)
FIGURE 59.TAKARA BIO, INC.: NET SALES ,($MILLION)
FIGURE 60.PHC HOLDINGS CORPORATION.: NET SALES ,($MILLION)
FIGURE 61.MILTENYI BIOTEC.: NET SALES ,($MILLION)
FIGURE 62.CANDOR BIOSCIENCE GMBH.: NET SALES ,($MILLION)
FIGURE 63.SAKURA FINETEK JAPAN CO., LTD.: NET SALES ,($MILLION)
FIGURE 64.EAGLE BIOSCIENCES, INC..: NET SALES ,($MILLION)
FIGURE 65.BIOCARE MEDICAL, LLC.: NET SALES ,($MILLION)
FIGURE 66.ELABSCIENCE, INC..: NET SALES ,($MILLION)
FIGURE 67.BIOGENEX LABORATORIES.: NET SALES ,($MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security